Prism Biotech

Prism Biotech

Prelaunch prescriber profiling and targeting

Overview

Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.

About Prism Biotech

Simplify's Rating
Why Prism Biotech is rated
C
Rated C on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Biotechnology

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Merion Township, Pennsylvania

Founded

2019

Get referred to Prism Biotech

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ono paid PRISM a milestone in November 2025, validating PepMetics execution.
  • E7386 Phase 1 results were published in January 2026, extending clinical credibility.
  • March 2026 Receptor.AI deal adds AI-driven discovery leverage for difficult targets.

What critics are saying

  • August 2026 nine-month loss widened to ¥845.7 million; burn remains heavy.
  • Servier terminated its collaboration in October 2025, proving partner churn hits PRISM.
  • September 2026 cash burn and no guidance set up a dilutive 2027 financing crunch.

What makes Prism Biotech unique

  • PepMetics targets intracellular protein-protein interactions, a hard, scarce drug-discovery niche.
  • PRISM BioLab monetizes by out-licensing programs to Eisai, Ono, and Servier.
  • 2026 collaborations with Receptor.AI and Talus deepen platform optionality.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

Prism Biotech is Hiring for 208 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →